Skip to content

Ocurrence of temporomandibular disorder symptoms with the use of orthodontic aligners

Incidence of temporomandibular disorder symptoms with the use of orthodontic aligners

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3fwtryt
Enrollment
Unknown
Registered
2021-11-29
Start date
2021-09-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Dysfunction Syndrome

Interventions

The samples will be from 19 participants, collected at the private dental clinic AB Odontologia in Belém,Pará , from September 2021 to December 2021. All participants will be treated only with orthodo
E05.318.308.980

Sponsors

Ana Luiza Corrêa da Silva
Lead Sponsor
Faculdade São Leopoldo Mandic
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patient who agreed to sign the consent form; patients with no symptoms of TMD( temporomandibular dysfunction) or orofacial pain

Exclusion criteria

Exclusion criteria: current use of muscle relaxants or any medication that affects masticatory muscle activity; presence of any systemic disorder affecting motor behavior and pain perception;daily use of any analgesic;orthodontic treatment that requires extractions;and neurological or psychiatric problems

Design outcomes

Primary

MeasureTime frame
The CD/TDM(Temporomandibular dysfunction) symptom questionnaire will be applied to patients before starting treatment to exclude the presence of TMD( Temporomandibular dysfunction) symptoms. After 4 weeks of starting treatment, participants will again answer the CD/TDM symptom questionnaire to find out if any patients have developed TMD symptoms. Within 8 weeks, the questionnaire will be reapplied to assess whether the individual remains symptomatic or if new symptoms suggest, or if symptoms improve and new patients with symptoms suggest. It will also be evaluated which was the most prevalent symptom among patients.

Secondary

MeasureTime frame
Evaluate the difference in symptoms among research patients, which period the symptoms of temporomandibular disorders developed and whether symptoms improved or persisted during the research period.

Countries

Brazil

Contacts

Public ContactAna Luiza Silva
correa_analuiza@yahoo.com.br+559132419872

Outcome results

None listed

Source: REBEC (via WHO ICTRP)